The RAS-RAF-MEK-MAPK intracellular signaling pathway is one of the most commonly mutated oncogenic pathways in cancer with the BRAF V600E mutation previously described at a high frequency in malignant melanoma, papillary thyroid cancer, and colorectal cancer [4]. This evidence concerns the gene BRAF and cancer.